drugset / Trial / NCT06695468

Efficacy and Safety of Adding Dexmedetomidine to Levobupivacaine in Rectus Sheath Block Compared to Quadratus Lumborum Block in Patients Undergoing Lower Abdominal Cancer Surgery: A Randomized Clinical Trial

NCT06695468

Phase 4 Not yet recruiting 122 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Surgical trauma activates numerous receptors leading to severe postoperative pain. Seventy to seventy-five percent of the pain is somatic, originating from the anterior abdominal wall, and it often persists for 72 hours after open surgery. The objective of this study is to compare the efficacy and safety of adding dexmedetomidine to Levobupivacaine in rectus sheath block with quadrates lumborum block in patients undergoing lower abdominal cancer surgeries.

Timeline

Start
2024-12-01
Primary completion
2026-12-01
Completion
2027-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1.5 ug/kg Other
Subject Levobupivacaine Other / unclassified 20 ml Other
Subject Levobupivacaine Other / unclassified 30 ml Other

Indications